Prevalence of HIV-related thrombocytopenia among clients at Mbarara regional referral hospital, Mbarara, Southwestern Uganda

Journal of Blood Medicine

Volumn 6, Issue , 2015, Pages 109-113

  Taremwa, Ivan M ^a   Muyindike, Winnie R ^b   Muwanguzi, Enoch ^a   Boum, Yap ^a,c   Natukunda, Bernard ^a  

^a MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^b Mbarara Hospital   (Uganda)

^c EPICENTRE   (France)

Author keywords

AIDS; Antiplatelet antibodies; Cytopenia

Indexed keywords

GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; IMMUNOGLOBULIN G; THROMBOCYTE ANTIBODY; THROMBOCYTE ANTIGEN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD ANALYSIS; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SUPPRESSED SYNDROME; IMMUNOPATHOLOGY; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; UGANDA;

EID: 84939120831     PISSN: None     EISSN: 11792736     Source Type: Journal    
DOI: 10.2147/jbm.s80857     Document Type: Article

References (30)

1. Cosby CD. Hematological disorders associated with human immunodeficiency virus and AIDS. J Infus Nurs. 2007;30(1):22–32.
2. Giles. C. The platelet count and mean platelet volume. Br J Haematol. 1981;48(1):31–37.
3. Dacie JV, Lewis SM. Practical Haematology. 7th ed. Edinburgh: Elsevier Churchill Livingstone; 1991.
4. Sloand EM, Klein HG, Banks SM, Vareldzis B, Merritt S, Pierce P. Epidemiology of thrombocytopenia in HIV infection. Eur J Haematol. 1992;48(3):168–172.
5. Liebman H. Other immune thrombocytopenias. Semin Hematol. 2007;44(4 Suppl 5):S24–S34.
6. Ballem PJ, Belzberg A, Devine DV, et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Eng J Med. 1992;327(25):1779–1784.
7. McDonald EJ. and Butler A. Immune thrombocytopaenia in adults: a single-centre retrospective review of patients presenting over 7 years. N Z Med J. 2010;123(1312):18–25.
8. Coyle TE. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin North Am. 1997;81(2):449–470.
9. Johannessen A, Naman E, Ngowi BJ, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis. 2008;8:52.
10. Racoosin JA, Kessler CM. Bleeding episodes in HIV-positive patients taking HIV protease inhibitors: a case series. Haemophilia. 1999;5(4): 266–269.
11. Natukunda B. Post-Transfusion and Maternal Red Blood Cell Alloimmunization in Uganda [doctoral thesis]. Leiden: Leiden University; 2013.
12. Alaei K, Alaei A, Mansoori D. Thrombocytopenia in HIV-infected patients, Islamic Republic of Iran. East Mediterr Health J. 2000;8(6): 758–764.
13. Addis Z, Yitayew G, Tachebele B. Prevalence of some hematological abnormalities among HIV positive patients on their first visit to a tertiary health institution in Ethiopia; A cross sectional study. International Blood Research and Reviews. 2014;2(6):270–278.
14. Akinbami A, Olajumoke O, Titilope A, et al. Hematologic abnormalities in treatment-naive HIV patients. Infect Dis (Auckl). 2010;3:45–49.
15. Munyazesa E, Emile I, Mutimura E, et al. Assessment of haematological parameters in HIV-infected and uninfected Rwandan women: a cross-sectional study. BMJ Open. 2012;2(6):e001600.
16. Kyeyune R, Saathoff E, Ezeamama AE, Löscher T, Fawzi W, Guwatudde D. Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda. BMC Infect Dis. 2014;14:496.
17. Wondimeneh Y, Muluye D, Ferede G. Prevalence and associated factors of thrombocytopenia among HAART-naive HIV-positive patients at Gondar University Hospital, Northwest Ethiopia. BMC Res Notes. 2014;7:5.
18. Li Z, Nardi MA, Karpatkin S. Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia. Blood. 2005;106(2):572–576.
19. Moses A Nelson J, Bagby GC Jr. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood. 1998;91(5):1479–1495.
20. Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009;46(1 Suppl 2):S2–S14.
21. Enawgaw B, Alem M, Addis Z, Melku M. Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naive in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study. BMC Hematol. 2014;14:8.
22. Montaner JS, Le T, Fanning M, et al. The effect of zidovudine on platelet count in HIV-infected individuals. J Acquir Immune Defic Syndr. 1990;3(6):565–570.
23. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results From the Multistate Adult and Adolescent Spectrum of HIV Disease Surveillance Project. Blood. 1998;91(1):301–308.
24. Berhane K, Karim R, Cohen MH, et al. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women’s Interagency HIV Study. J Acquir Immune Defic Syndr. 2004;37(2):1245–1252.
25. Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19(1): 29–33.
26. Ferede G, Wondimeneh Y. Prevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital, Northwest Ethiopia. BMC Hematol. 2013;13:8.
27. Palomo I, Alarcón M, Sepulveda C, Pereira J, Espinola R, Pierangeli S. Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients. J Clin Lab Anal. 2003;17(6):209–215.
28. Riccio A, Natale D, Fratellanza G, et al. The lack of correlation between the positivity of anti-platelet antibodies and the presence of thrombocytopenia in course of HIV infection. Boll Soc Ital Biol Sper. 1993;69(3): 203–208.
29. Aster RH, Newman PJ. HPA-1a/b(PlA1/A2, Zwa/b): the odyssey of an alloantigen system. Immunohematology. 2007;23(1):2–8.
30. Kaplan C, Morel-Kopp MC, Kroll H, et al. HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases. Br J Haematol. 1991;78(3):425–429.